About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Dr. Lal Pathlabs Ltd.
Industry :
Hospital & Healthcare Services
BSE Code
539524
ISIN Demat
INE600L01024
Book Value
279.43
NSE Code
LALPATHLAB
Dividend Yield %
0.76
Market Cap
264072.97
P/E
49.09
EPS
64.21
Face Value
10
BSE
NSE
04-Nov-2025
BSE
NSE
NSE F & O
04-Nov-2025
BSE
NSE
NSE F & O
Last Price
3152.15
Net Change
-99.5
% Change
-3.06%
Prev.Close
3251.65
Open
3234.35
High
3253.05
Low
3133.00
Volume
6170
Last Price
3153.70
Net Change
-101.2
% Change
-3.11%
Prev.Close
3254.90
Open
3249.80
High
3250.00
Low
3130.10
Volume
144892
Value
19640952
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
3253.05
52-Week High
3542.60
52-Week Low
2295.10
Value
458606128.6
Best Buy
3153.70
Best Sell
0.00
Best Quantity
13
Sell Quantity
0
Today's Range
3250.00
52-Week High
3540.00
52-Week Low
2293.55
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
13
Price
3153.70
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
06-Aug-19
12-Aug-19
Dividend
70 %
07-Nov-25
Company News
01-11-2025
Dr. Lal PathLabs informs ...
01-11-2025
Dr. Lal PathLabs informs ...
24-09-2025
Dr. Lal PathLabs informs...
24-09-2025
Dr. Lal Pathlabs gets nod...
20-08-2025
Dr. Lal Pathlabs pioneers...
20-08-2025
Dr. Lal PathLabs informs...
20-08-2025
Dr. Lal Pathlabs surges o...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.